LintonPharm
PrivateCompany Overview
LintonPharm is a biotechnology company that develops innovative T cell engaging bispecific antibodies for cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LintonPharm Comparables
Compare LintonPharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lindis Biotech | 87% | |
| ITabMed Ltd. | 81% | |
| BioAtla | 80% |
LintonPharm Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors grew 828% MoM, from 65 to 603.
- Jul 3, 2025
Monthly visitors increased 42% MoM.
LintonPharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LintonPharm's valuation, stock price, and market status.
Is LintonPharm a public or private company?
LintonPharm is a private company.
What is the current stock price of LintonPharm?
LintonPharm is a private company with no public stock price. Caplight tracks LintonPharm's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is LintonPharm worth (valuation)?
Valuation information for LintonPharm is not publicly available.
Can I buy LintonPharm stock?
LintonPharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LintonPharm's last funding round?
Funding round information for LintonPharm is not publicly available.
Who are the main investors in LintonPharm?
Investor information for LintonPharm is not publicly disclosed.
Will LintonPharm IPO soon?
No public IPO plans have been announced for LintonPharm.
How can I track LintonPharm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LintonPharm's secondary market activity and sign up for updates.